Cargando…
Posttransplant Lymphoproliferative Disease after Lung Transplantation
Posttransplant lymphoproliferative disease (PTLD) after lung transplantation occurs due to immunosuppressant therapy which limits antiviral host immunity and permits Epstein-Barr viral (EBV) replication and transformation of B cells. Mechanistically, EBV survives due to latency, escape from cytotoxi...
Autor principal: | Neuringer, Isabel P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603163/ https://www.ncbi.nlm.nih.gov/pubmed/23533455 http://dx.doi.org/10.1155/2013/430209 |
Ejemplares similares
-
Posttransplant Lymphoproliferative Disease after Pediatric Solid Organ Transplantation
por: Mynarek, Martin, et al.
Publicado: (2013) -
Posttransplant Lymphoproliferative Disorders
por: Ibrahim, Hazem A. H., et al.
Publicado: (2012) -
Thymic Hyperplasia after Lung Transplantation Imitating Posttransplant Lymphoproliferative Disorder
por: Steger, Christina Maria, et al.
Publicado: (2011) -
Editorial: Infections and posttransplant lymphoproliferative disease after pediatric kidney transplantation
por: Kizilbash, Sarah J., et al.
Publicado: (2023) -
Hematopoietic Stem Cell Transplantation after Posttransplant Lymphoproliferative Disorder
por: Kim, Min Joo, et al.
Publicado: (2010)